People

Our Team

AI Therapeutics boasts a highly accomplished team with executional expertise across all stages of clinical development.

Leadership

Brigette Roberts, M.D.

Acting CEO

Scott B Kozak

Chief Business Development Officer

Peter Young, Ph.D.

Chief Scientific Officer

Keith Fandrick, Ph.D.

Chief Development Officer

Joan Edwards

Chief Quality Assurance Officer

Brad Parry, Ph.D.

Head of AI

Board of Directors

Jonathan Rothberg, Ph.D.

George Rehm

Management

No items found.

Scientific Advisory Board

Lawrence Melvin, Ph.D.

Murat Gunel, M.D.

Chair

Tian Xu, Ph.D.